泰尼特医疗 THC

Dr. Sutaria was appointed Chairman of the Board in August 2023, having previously been named Chief Executive Officer in September 2021 and a member of the Board in November 2020. Prior to becoming Chief Executive Officer, he served as the Company's Chief Operating Officer from January 2019 to September 2021 and as President from November 2019 to September 2021. Before joining the Company, Dr. Sutaria spent 18 years at McKinsey and Company, a global management consulting firm, most recently serving as a Senior Partner where he provided advisory support to hospitals, healthcare systems, physician groups, ambulatory care models, integrated delivery networks, and government led delivery systems, while also advising institutional investors in the healthcare sector. Earlier in his career, he held an associate clinical faculty appointment at the University of California at San Francisco and completed postgraduate training with a focus on internal medicine and cardiology. Dr. Sutaria earned a Bachelor's Degree in molecular and cellular biology and a Bachelor's Degree in economics from the University of California at Berkeley, as well as a Medical Degree from the University of California at San Diego.

Mr. Arnst was appointed Tenet's Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary in April 2021. In this capacity, he leads enterprise Human Resources, Legal and Government Relations. He also serves as Chief Risk Officer. Prior to assuming these roles, Mr. Arnst served as Chief Administrative Officer, General Counsel and Corporate Secretary of our Conifer subsidiary. He has 35 years of experience working in leadership roles across healthcare, outsourcing and financial services, among other industries. Before joining Conifer in 2018, Mr. Arnst served as Chief Administrative Officer at Millennium Health. Previous positions also include Executive Vice President, Chief Administrative Officer, General Counsel, Head of Global Human Resources and Corporate Secretary at Expert Global Solutions. During his career, Mr. Arnst has also held executive leadership positions at Safety-Kleen, AmeriServe, RailTex and Ryder. He is a graduate of the University of Miami, where he received his Juris Doctor and his Master of Laws. He obtained his Bachelor of Business Administration degree in Finance from Florida Atlantic University.

Ms. Foo was promoted to Executive Vice President and Chief Operating Officer (COO) in May 2025 from her prior role as Executive Vice President, Commercial Operations, to which she was appointed in March 2022. As COO, Ms. Foo oversees hospital operations and leads several enterprise functions, including strategy, business development, marketing, procurement, and data, artificial intelligence and analytics. She previously served as Vice President, Chief Commercial and Strategy Officer from April 2019 to March 2022. Prior to that, Ms. Foo held various positions at McKinsey & Company, a global management consulting firm, including Associate Partner from 2017 to 2019 in the San Francisco office. She earned her Bachelor of Science in Biological Engineering from Massachusetts Institute of Technology.

Mr. Park was appointed Tenet's Chief Financial Officer in January 2024 and Executive Vice President in July 2023. He previously served as Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution and Strategic Global Sourcing of AmerisourceBergen Corporation (AmerisourceBergen), a global pharmaceutical sourcing and distribution services company, beginning in September 2018. From 2012 to September 2018, Mr. Park was Executive Vice President of Strategy and Development for AmerisourceBergen. Before joining AmerisourceBergen, he served in various leadership roles across corporate development, corporate strategy and R&D portfolio management at MedImmune, the global biologics division of AstraZeneca. Before joining MedImmune, he held positions at Charterhouse Group International and Merrill Lynch & Company. Mr. Park earned a Bachelor of Arts in Economics and a Bachelor of Arts in Biochemistry from Yale University.

Ms. Arbour was appointed Tenet's Chief Information Officer in May 2018 and Executive Vice President in March 2019. In this capacity, Ms. Arbour oversees the leadership and strategic direction for Tenet's information technology (IT) systems and identifies opportunities to support the Company's expansive care network through the application of digital technology, data and automation, and customer experience. Ms. Arbour previously held the title of Senior Vice President from May 2018 to February 2019. Prior to Tenet, Ms. Arbour served as President at ProV International, a technology consulting firm, from November 2017 to April 2018, Vice President Services Global Delivery at ServiceNow, a software company, from July 2016 to September 2017, and as Vice President of Service Delivery at Dell Services from December 2010 to April 2016. From 1985 to 2009, Ms. Arbour held several leadership roles within IT operations at Electronic Data Systems - both at the company's headquarters and also in London and Frankfurt. In July 2021, Ms. Arbour was appointed to the board of directors of Texas Capital Bancshares, Inc. Ms. Arbour earned her bachelor's degree in telecommunications arts and sciences from Michigan State University. On April 9, 2026, Tenet Healthcare Corporation and Paola Arbour entered into a Retirement Transition Agreement and General Release that provides that Ms. Arbour will retire from her role as Executive Vice President and Chief Information Officer effective December 31, 2026.

Mr. J. Robert Kerrey is a former Governor and United States Senator from Nebraska. He has served as a Managing Director at Allen and Company, an investment banking firm, since 2014. From 2011 to 2013, he held the title of President Emeritus of The New School University in New York City, where he previously served as President from 2001 to 2010. He also served as Chairman of M and F Worldwide Education Holdings from 2011 to 2012. Senator Kerrey represented the State of Nebraska as a United States Senator from 1989 to 2000 and earlier served as Governor of Nebraska from 1982 to 1987. Prior to entering public service, he founded and operated a chain of restaurants and health clubs. A former member of the elite Navy SEAL Team, Senator Kerrey is a highly decorated Vietnam veteran who was awarded the Congressional Medal of Honor, the highest military honor in the United States. He holds a degree in pharmacy from the University of Nebraska. Prior Public Company Directorships Within the Past Five Years: Lux Health Tech Acquisition Corp.

Ms. Romo retired in April 2025 as Executive Vice President and Chief Financial Officer of Southwest Airlines Co., a major passenger airline, where she was responsible for corporate strategy and all finance related activities, including reporting, accounting, investor relations, treasury, tax, corporate planning, and financial planning and analysis, as well as oversight of supply chain management. During her career at Southwest Airlines, she served in numerous financial management and leadership roles, including Senior Vice President of Planning, Vice President and Controller, Vice President and Treasurer, and Senior Director of Investor Relations. Prior to joining Southwest Airlines in 1991, Ms. Romo worked as an audit manager at Coopers and Lybrand LLP. She currently serves as a member of the McCombs School of Business Advisory Council at the University of Texas at Austin. Ms. Romo earned a Bachelor of Business Administration degree in accounting from the University of Texas at Austin and is a Certified Public Accountant in the State of Texas. Other Current Public Company Directorships: Ryder Systems, Inc.

Admiral Haney is a retired four star Admiral who completed 38 years of service in the United States Navy in 2017. From 2013 to 2016, he served as Commander of the United States Strategic Command, where he was responsible for strategic capabilities involving nuclear forces, missile defense, space, and cyberspace. From 2012 to 2013, he served as Commander of the United States Pacific Fleet, overseeing United States Navy operations as well as the manning, operations, and maintenance of Navy forces located in the Pacific and Indian Oceans. Admiral Haney currently serves on the Johns Hopkins University Applied Physics Board of Managers, the Penn State University Applied Research Laboratory Advisory Board, the Naval Studies Board, the Aerospace Corporation Board of Trustees, and the Boards of Directors of General Dynamics Corporation, Systems Planning and Analysis Inc., and the Center for New American Security. He also serves as Chairman of the Board of Directors of the Military Child Education Coalition. Admiral Haney is a graduate of the United States Naval Academy and holds a Master's degree in National Security Strategy from the National Defense University, as well as Master's degrees in Engineering Acoustics and System Technology from the Naval Postgraduate School. Other Current Public Company Directorships: General Dynamics Corporation

Mr. Fisher served as President and Chief Executive Officer of the Federal Reserve Bank of Dallas from 2005 until 2015, during which time he was a member of the Federal Open Market Policy Committee, chaired the Conference of Federal Reserve Bank Presidents, and served as chair of the Information Technology Oversight Committee for the twelve Federal Reserve banks. Previously, from 2001 to 2005, he was Vice Chairman of Kissinger McLarty Associates, a strategic advisory firm. From 1997 to 2001, Mr. Fisher served as Deputy United States Trade Representative with the rank of Ambassador. Over the last ten years, he has held a number of advisory roles, including serving as Senior Advisor for Barclays PLC, a leading investment bank, from 2015 to 2024, and more recently being appointed Senior Advisor for Jefferies Financial Group Inc. in April 2024 and Senior Advisor to the Texas Stock Exchange in July 2024. He has also served as a Trustee of the University of Texas Southwestern Medical Foundation. Mr. Fisher earned a Bachelor of Arts degree in economics from Harvard University and a Master of Business Administration degree from Stanford University. Other Current Public Company Directorships: Warner Bros. Discovery, Inc. Prior Public Company Directorships Within the Past Five Years: AT&T Inc., Beneficient ,PepsiCo, Inc. Beneficient

Mr. Bierman served as President and Chief Executive Officer of Owens and Minor Inc., a Fortune 500 company and a leading distributor of medical and surgical supplies, from September 2014 to June 2015. Prior to that role, he held several senior leadership positions at Owens and Minor, including President and Chief Operating Officer from August 2013 to September 2014, Executive Vice President and Chief Operating Officer from March 2012 to August 2013, Executive Vice President and Chief Financial Officer from April 2011 to March 2012, and Senior Vice President and Chief Financial Officer from June 2007 to April 2011. From 2001 to 2004, Mr. Bierman served as Executive Vice President and Chief Financial Officer at Quintiles Transnational Corp., and prior to joining Quintiles Transnational, he was a partner at Arthur Andersen LLP. Mr. Bierman earned a Bachelor of Arts degree from Dickinson College and a Master of Business Administration degree from Cornell University's Johnson Graduate School of Management. Other Current Public Company Directorships: MiMedx Group, Inc Prior Public Company Directorships Within the Past Five Years: KL Acquisition Corp. Novan, Inc. .

Ms. FitzGerald is a private equity investor who serves as an advisor to several firms, including Goldman Sachs, TowerBrook, and Wellspring Capital, a private equity firm focused on leveraged buyout investments. In addition, she serves as an Adjunct Professor of Health Policy at Columbia University. From December 2016 to January 2020, Ms. FitzGerald served as Chief Executive Officer and managing partner of Letter One's inaugural health investment vehicle. Prior to this role, she spent nearly 20 years as an operator and strategist working with numerous healthcare companies, including Merck, Pfizer, and Medco. Between May 2015 and October 2016, she served as Executive Vice President of Strategy and Policy at Cardinal Health, and from 2010 to 2015 she was President of Cardinal Health's Specialty Solutions division. Ms. FitzGerald has also served as a director of Thimble Point Acquisition Corp. from February 2021 to December 2021 and of Arix Bioscience plc from 2017 to 2019. She is the founder of K2HealthVentures, a life science investment fund. Ms. FitzGerald holds a Doctor of Public Health degree in healthcare policy from New York Medical College, a Bachelor of Science in Nursing from Fairfield University, and a Master of Public Health degree from Columbia University. Other Current Public Company Directorships: Roivant Sciences Ltd. Prior Public Company Directorships Within the Past Five Years: Thimble Point Acquisition Corp.

Mr. Mark retired in August 2022 as Chairman and President of Ameren Illinois Company, a multibillion dollar energy and utility company responsible for electric and natural gas distribution to more than 1.2 million electric customers and 800,000 natural gas customers across Illinois. He joined Ameren in 2002 as Vice President of Customer Service and subsequently progressed through a number of senior management roles within the organization. Prior to joining Ameren, Mr. Mark spent 11 years at Ancilla Systems Inc., the parent company of St. Mary's Hospital in East St. Louis, Illinois, where he served as Vice President for Governmental Affairs and Chief Operating Officer before becoming Chief Executive Officer of St. Mary's Hospital from 1994 to 2002. In addition, he served as a Director of Union Electric Company from 2005 to 2012 and as Chairman of Ameren Illinois, both subsidiaries of Ameren Corporation, from 2012 to 2022. Mr. Mark earned a Bachelor of Science degree from Iowa State University and a Master of Science degree from National Louis University. Other Current Public Company Directorships: Sempra

Mr. Lynch served as National Partner in Charge of the Financial Services practice at KPMG LLC from 2004 until his retirement in 2007. Prior to that, he spent 29 years at KPMG in a variety of senior leadership roles, including serving as chair of KPMG's Americas Financial Services Leadership team, as a member of the Global Financial Services Leadership team and the United States Industries Leadership team, and as an audit signing partner for several of KPMG's largest publicly traded financial services audit clients. From 2009 to 2022, Mr. Lynch served as an independent director of American International Group Inc. From 2008 to 2019, he also served as an independent director of Freddie Mac and held the role of Non Executive Chairman of the Board from 2011 to 2018. He has chaired the audit committees of both AIG and Freddie Mac and has extensive committee experience in Risk, Compensation, Nomination and Corporate Governance, and Technology. Mr. Lynch is a former member of the Advisory Board of the Stanford Institute for Economic Policy Research and is a member of the Audit Committee Chair Advisory Council of the National Association of Corporate Directors. He earned a Bachelor of Science degree in Accounting and Business Administration from the University of Kansas. Other Current Public Company Directorships: Corebridge , Prior Public Company Directorships Within the Past Five Years: American International Group, Inc.

Senator Blunt has served as Chairman of the Leadership Advisory Strategies group at Husch Blackwell Strategies, an advisory firm, since April 2023. From 2011 to 2023, he represented the State of Missouri as a United States Senator, during which time he served as Chairman of the Senate Rules Committee and was also a member of the Senate Appropriations Committee, the Senate Commerce, Science and Transportation Committee, and the Senate Select Committee on Intelligence. Prior to his service in the Senate, he served as a member of the United States House of Representatives from 1997 to 2011, representing Missouri's Seventh Congressional District. Before his congressional career, Senator Blunt served four years as President of Southwest Baptist University from 1993 to 1996. Earlier in his public service career, he served as Missouri's Secretary of State from 1985 to 1993. Prior Public Company Directorships Within the Past Five Years: Southwest Airlines Co.

Dr. Agarwala has served as a General Partner at Andreessen Horowitz, also known as a16z, since January 2020, where she leads investments for the firm's Bio and Health fund across biotechnology and digital health. In addition to her role in venture capital, she has been an Adjunct Clinical Assistant Professor at the Stanford University School of Medicine since 2020. From August 2016 to June 2018, Dr. Agarwala served as Director of Product Management at Flatiron Health, where she led the company's partnership with Foundation Medicine to integrate real world clinical and genomic data into national scale data products aimed at accelerating research and development in oncology. Between March 2015 and December 2019, she worked as a venture investor on the GV, formerly known as Google Ventures, life sciences team. Dr. Agarwala holds both M.D. and Ph.D. degrees from Harvard Medical School and the Massachusetts Institute of Technology, as well as a Bachelor of Science degree in biophysics from Stanford University. She completed her clinical residency at Stanford University and is board certified in internal medicine.

Dr. West is a retired Lieutenant General in the United States Army who served as the 44th Surgeon General of the United States Army and as the former Commanding General of the United States Army Medical Command. Earlier in her career, she served as Joint Staff Surgeon at the Pentagon, where she acted as the chief medical advisor to the Chairman of the Joint Chiefs of Staff and coordinated all related health services matters, including operational medicine, force health protection, and military readiness. Dr. West has extensive experience that includes combat deployments as well as senior leadership roles in multiple hospitals in the United States and internationally. She has received numerous United States military honors, including the Distinguished Service Medal, the Defense Superior Service Medal, and the Legion of Merit with three Oak Leaf Clusters. Since 2019, she has served as an independent director of Nucor Corporation, and since 2020, she has served as an independent director of Johnson and Johnson. Dr. West has also been a trustee on the Board of the National Recreation Foundation, a nonprofit organization focused on enhancing recreation as a positive force for improving youth quality of life, since 2019. She is a graduate of the United States Military Academy and earned her medical degree from The George Washington University School of Medicine in Washington D.C., and she has completed residencies in both family medicine and dermatology. Other Current Public Company Directorships: Johnson & Johnson, Nucor Corporation, Tempus AI, Inc.

On March 25, 2026, the Company appointed J. Michael Grooms, Senior Vice President and Controller of the Company, effective April 6, 2026. Mr. Grooms has served as Senior Vice President, Chief Accounting Officer for Lifepoint Health, Inc. (Lifepoint), a healthcare provider that serves patients, clinicians, communities and partner organizations across the healthcare continuum, since 2018. Between 2006 and 2018, Mr. Grooms held various other reporting and accounting leadership roles of increasing responsibility at Lifepoint. Mr. Grooms began his career in public accounting as an auditor with KPMG.